Not long ago, Zhejiang Canaan Zhiyao officially signed a contract with Shenhua Pharmaceutical's oral liquid production line MES system project, and the two sides reached a strategic cooperation
to jointly build a digital production line of Brainxinshu oral liquid.
Due to the complex production process, high product quality requirements and strict production process control requirements, the digital production line of CenoCardio Oral Liquid jointly built by Shenhua Pharmaceutical and Canaan Zhi Pharmaceutical will break the information islands in the workshop and the company through the SCADA and MES systems of Canaan Zhi Pharmaceutical on the basis of the existing automation of Shenhua Pharmaceutical, and help Shenhua Pharmaceutical achieve a high degree of digital integration, informatization of the whole production process, material and quality control and traceability
.
Pharmaceutical equipment companies and pharmaceutical companies continue to "marry" and jointly break the digital transformation and upgrading (Image source: Pharmaceutical Network)
It is understood that the traditional pharmaceutical production model often has low production efficiency, low management level and other defects, difficult to meet the needs of the high-quality development of the modern pharmaceutical industry, in recent years, with the rapid development of cloud computing, 5G, Internet, big data and other new generation information technology, the manufacturing industry accelerates the transformation of intelligent manufacturing, embracing digitalization has also become the direction
of more and more traditional pharmaceutical companies transformation.
In March 2022, the Ministry of Industry and Information Technology and other nine ministries and commissions issued the "14th Five-Year Plan" for the development of the pharmaceutical industry, which clearly proposed to promote the digital transformation and upgrading of the pharmaceutical industry, improve the normalization level of the pharmaceutical supply chain, and further strengthen the direction of the transformation of
traditional pharmaceutical enterprises.
Through digital and intelligent transformation, pharmaceutical companies are conducive to improving production efficiency and management level, thereby improving product quality.
On the other hand, it is also conducive to reducing labor costs and better coping with the challenges
brought by factors such as centralized procurement price reduction, medical insurance control fees, and rising labor costs year by year.
However, the intelligent and digital transformation of pharmaceutical companies is not achieved overnight, but a continuous change and gradual process
.
In the process of embracing digitalization, pharmaceutical companies may face a series of challenges
such as lack of top-level design, data silos, lack of digital talents, and security compliance requirements.
In this context, the cooperation between pharmaceutical companies and upstream pharmaceutical equipment companies in the field of pharmaceutical digitalization is constantly emerging, and jointly break the digital transformation and upgrading
.
In addition to Canaan Zhi Pharmaceutical and Shenhua Pharmaceutical, for example, on September 20, 2022, Chutian Technology mentioned at the cooperation symposium with Wanbang Pharmaceutical that it is willing to strengthen cooperation with Wanbang Pharmaceutical in medical equipment and overall technical solutions, based on efficient and high-quality research and development, to provide strong support
for promoting the development of smart pharmaceutical factories.
It is reported that relying on long-term technology accumulation and continuous investment in R&D and innovation, Chutian Technology has successively provided intelligent system solutions in various segments for customers in the pharmaceutical industry at home and abroad in recent years, and achieved good results
.
On September 26, 2022, Dongfulong, which has the corporate vision of becoming a smart pharmaceutical factory deliverer, announced that it will "hold hands" with Tianjin Jieke, and the two parties will carry out in-depth cooperation
in various fields such as upstream and downstream process design and development of biological drugs, plant design consulting, GMP production line equipment, core consumables, plant construction, and digital intelligent chemical plants.
It is reported that Tianjin Jieke can use Dongfulong's intelligent platform to cooperate in process design and development and other related businesses
.
For example, Chengyitong and pharmaceutical companies have also launched a series of cooperation in the field of digitalization, the company said on the interactive platform in October 2022 that the company can provide intelligent manufacturing overall solutions to pharmaceutical enterprises and biological product manufacturers, and the company's intelligent manufacturing overall solution integrates automatic control systems, software and intelligent equipment to help customers improve the level of automation, digitalization and intelligence, and realize production automation control and intelligent management
.
It is reported that at present, the company's business covers three major sectors
: pharmaceutical and biological intelligent manufacturing, rehabilitation medical equipment and plant extraction R & D and application.
According to data from the National Industrial Information Security Development Research Center, more than half of China's pharmaceutical companies are still in a state of single-point informatization and digital coverage, with low integration between systems, and many pharmaceutical manufacturing enterprises are still in the initial stage
of digitalization.
With the deepening of cooperation between pharmaceutical equipment enterprises and pharmaceutical companies, it is expected that the digital transformation and upgrading of the pharmaceutical industry will accelerate, which will reshape
the ecology of the entire pharmaceutical industry.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
